First AXL1717 clinical data from ongoing phase I/II study in cancer patients has been published
STOCKHOLM, September 7, 2010. Axelar AB today announces that the first submitted medical article on the ongoing phase I/II cancer study with AXL1717 has been published in Acta Oncologica.The article, including clinical data from a limited group of AXL1717-treated patients, by Drs. Ekman, Bergqvist, Frödin and colleagues, was recently published in Acta Oncologica, Early Online 1-7, 2010. The publication describes four heavily pretreated patients with progressive and advanced squamous non-small cell lung cancer (NSCLC) without any remaining therapeutic options. The patients were treated with